Form 4: ULTRALIFE Director Boosts Stake with Share Purchase

ULTRALIFE Corp. Director Robert W. Shaw acquired 1,750 shares of common stock at $5.67 per share, increasing his direct beneficial ownership to 71,000 shares.

Summary

• Robert W. Shaw, a Director of ULTRALIFE Corp. (ULBI), purchased 1,750 shares of common stock.
• The transaction occurred on November 24, 2025, at a price of $5.67 per share.
• Following this purchase, Mr. Shaw directly beneficially owns a total of 71,000 shares of ULTRALIFE Corp. common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The purchase of shares by a director is a positive indicator of insider confidence, suggesting a belief in the company's future prospects. The 10b5-1 plan indicates a pre-planned investment.

Positives

• A Director, Robert W. Shaw, increased his stake in ULTRALIFE Corp. by purchasing 1,750 shares.
• Insider buying can signal management's confidence in the company's future prospects and valuation.
• The purchase was made at $5.67 per share, indicating a specific valuation point at which the insider found the stock attractive.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May view the director's purchase as a positive signal, potentially increasing confidence in the stock.

Key Dates

Recommendation

The purchase of company stock by a director, especially under a 10b5-1 plan, often signals strong insider confidence in the company's valuation and future prospects. This action suggests that management believes the stock is undervalued or poised for growth, making it a potentially attractive buying opportunity for investors.

Keywords

ULTRALIFE Corp, ULBI, Insider Trading, Form 4, Director Purchase, Stock Acquisition, Robert W. Shaw, Equity Securities, 10b5-1 plan